126456-36-8

Basic information

• Product Name: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate
• CAS NO: 126456-36-8
• Molecular Formula: C₃₃H₄₀N₂O₅
• Molecular Weight: 544.6811
• Mol File: 126456-36-8.mol

Chemical Properties

• Boiling Point: 795.5°C at 760 mmHg
• Flash Point: 434.9°C
• Density: 1.22g/cm³
• Vapor Pressure: 1.09E-26mmHg at 25°C
• Refractive Index: 1.615
• CAS DataBase Reference: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(126456-36-8)
• EPA Substance Registry System: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(126456-36-8)

Safety Data

• Hazardous Substances Data: 126456-36-8(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
Tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is used as a molecular scaffold for the development of new pharmaceutical agents due to its unique structural features and potential for functionalization. Its chiral centers and multiple functional groups allow for the fine-tuning of biological activity and selectivity towards specific targets.
Used in Drug Design and Optimization:
In the pharmaceutical industry, tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is used as a lead compound for drug design and optimization. Its complex structure provides a foundation for the creation of novel therapeutic agents with improved potency, selectivity, and pharmacokinetic properties.
Used in Chemical Synthesis:
Tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate serves as a versatile intermediate in organic synthesis, particularly for the synthesis of complex organic molecules and natural products. Its unique structural elements can be exploited to facilitate the construction of intricate molecular architectures.
Used in Research and Development:
In academic and industrial research settings, tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is used as a subject of study to explore its chemical properties, reactivity, and potential applications in various fields, including materials science, catalysis, and supramolecular chemistry.

Upstream product

• 147912-04-7 [(1S,2S,4R)-1-Benzyl-2-(tert-butyl-dimethyl-silanyloxy)-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid tert-butyl ester 
• 7480-35-5 trans-1-aminoindan-2-ol 
• 141018-42-0 [(1S,2S,4R)-1,4-Dibenzyl-5-((3aS,8aR)-2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester 
• 72155-45-4 Boc-L-phenylalaninal 
• 98818-48-5 C₃₆H₅₉NO₅Si₂ 
• 7480-35-5 (1S,2R)-1-amino-2-indanol 
• 98818-42-9 (3S,5S)-3-benzyl-5-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-phenylethyl}dihydrofuran-2-(3H)-one 
• 63516-03-0 α-bromo-p-toluidine 
• 193338-94-2 (5S,1'S)-carbetoxy-5-<1-<<(1',1-dimethylothoxy)carbonyl>amino>-2-phenylmethyl>dihydrofuran-2(3H)-one 
• 98760-08-8 (2R,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1,2-epoxy-4-phenylbutane 
• 7480-35-5 (+/-)-cis-1-amino-indan-2-ol 
• 141018-37-3 (3aS,8aR)-2,2-dimethyl-3-(3-phenylpropanoyl)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3]oxazole 
• 565454-73-1 (1,4-dibenzyl-2-oxo-pent-4-enyl)-carbamic acid tert-butyl ester 
• 98818-51-0 N-(1,1-dimethylethoxycarbonyl)-5(S)-amino-4(S)-(t-butyldimethylsilyloxy)-6-phenyl-2(R)-(phenylmethyl)hexanoic acid 

Downstream Products

• 145631-04-5 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid cyclopentyl ester 
• 145631-03-4 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (R)-(tetrahydro-furan-3-yl) ester 
• 145631-03-4 N-(2(R)-hydroxy-1(S)-indanyl)-5(S)-(3(S)-tetrahydrofuranyloxycarbonylamino)-4(S)-hydroxy-6-phenyl-2(R)-phenylmethyl hexanamide 
• 145631-05-6 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (R)-(tetrahydro-pyran-3-yl) ester 
• 145631-05-6 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (S)-(tetrahydro-pyran-3-yl) ester 

Relevant articles and documents

Allyltrichlorostannane additions to α-amino aldehydes: Application to the total synthesis of the aspartyl protease inhibitors L-682,679, L-684,414, L-685,434, and L-685,458

The hydroxyethylene dipeptide isosteres L-682,679, L-684,414, L-685,434, and L-685,458 were synthesized in a few steps by a sequence involving an allyltrichlorostannane coupling with an α-amino aldehyde, followed by hydroboration of the corresponding 1,2-

Short total synthesis of aspartyl protease inhibitors L-685,434, L-682,679 and L-685,458

Hydroxyethylene dipeptide isosteres L-685,434, L-682,679 and L-685,458 were synthesized in a few steps by a sequence involving an allyltrichlorostannane coupling with an α-aminoaldehyde followed by hydroboration of the corresponding 1,2-syn and 1,2-anti a

HIV protease inhibitors useful for the treatment of aids

Compounds of the form,ψ ψ A-G-Jψ ψ wherein A is an amine protecting group or urethane, G a dipeptide isostere and J a small terminal group are described. They are distinguished by tetrahydrofuryl or tetrahydropyranyl substituents, and the like. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.ψ

HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: An investigation into the role of the P1' side chain on structure-activity

A systematic investigation was undertaken to determine the role of the P1' sidechain in a series of hydroxyethylene isostere based inhibitors of HIV-1 protease. Substitution and homologation of the benzyl P1' side chain of the Phe-Phe isostere based pseudo peptides 1 (L-682,679) and 2 (L-685,434) with various heteroalkyl groups leads to a series of extremely potent inhibitors of the enzyme. Several examples of the most potent inhibitors were very effective in an ex vivo cell based viral spread assay using human H9 T- lymphocytes and the IIIb isolate of HIV-1. Compound 19 is 120 times more potent than 1 and 16 times more potent than 2 in inhibiting the spread of infection in this assay.

Highly Diastereoselective Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease

The nonchelate enforced chiral amide enolates derived from 4-7 react with alkyl iodide and protected α-amino epoxide electrophiles to produce the HIV protease inhibitors 10 and 16-19 with high diastereoselectivity.